Feedback
Liver Fibrosis, Non-Alcoholic Fatty Liver Disease (Echosens)
2012521
Ordering Recommendation

Only intended for use in patients with non-alcoholic liver disease (NAFLD); results may be inaccurate in patients with other etiologies of liver disease.

Mnemonic
FIBRO NAFL
Methodology
Quantitative Enzymatic/Quantitative Spectrophotometry/Automated Cell Count/Quantitative Chemiluminescent Immunoassay
Performed
Tue, Thu
Reported
1-5 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
Overnight fasting specimen is required. 
Collect
Lavender (EDTA) or Pink (K2EDTA) for platelet count AND Serum Separator Tube (SST). 
Specimen Preparation
Separate from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 1.2 mL) 
Storage/Transport Temperature
Serum: Frozen. Do not send the EDTA whole blood to ARUP. 
Unacceptable Conditions
Hemolyzed specimens. All required specimens not received. No platelet count received. No weight received. 
Remarks
This test requires an automated platelet count performed on the EDTA whole blood sample at the client site. Include the platelet count with the patient test submission information. This test requires the patient's weight (in pounds). Include the patient's weight with the sample submission. 
Stability
Serum: Ambient: 8 hours; Refrigerated: 48 hours; Frozen: 2 weeks 
Reference Interval
By report
Interpretive Data
Refer to report.

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
This test requires an automated platelet count performed on the EDTA whole blood sample at the client site. Include the platelet count with the patient test submission information. This test requires the patient's weight (in pounds). Include the patient's weight with the sample submission.
CPT Code(s)
(84450; 84460; 82728; 82947); (Alt code:81599* *The 2016 AMA CPT manual contains the component CPT Codes and the new MAAA codes.  Please direct any questions regarding CPT coding to the payer being billed.)
Components
Component Test Code*Component Chart NameLOINC
2005664FibroMeter Platelet Count26515-7
2005675FibroMeter Patient Score77616-1
2010928Aspartate Aminotransferase, FibroMeter1920-8
2010929Alanine Aminotransferase, FibroMeter1742-6
2012522Ferritin, Fibrometer2276-4
2012523Glucose, FibroMeter2345-7
2012524Weight, FibroMeter29463-7
2012635EER FibroMeter NAFL Enhanced Report11526-1
2013371FibroMeter NAFLD Interpretation48767-8
2013648Fibrosis Metavir Classification48794-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • FibroSure